Kura Stock Skyrockets On $150 Million Infusion Ahead Of Cancer Drug Test Results Kura Oncology (KURA) received a $150 million investment Wednesday, a week before it plans to unveil the test results for a cancer drug. Kura stock skyrocketed in early trades.